337) s index (BMI) with cardiovascular disease risk in a Chinese population. |
338) e, which revealed an increase in thrombus risk in a ventricle with DCM. |
339) enotoxic agents and constitutes a genetic risk in exposed human population. |
340) ons and suggests to consider the zoonotic risk in handling and eating meat from this |
341) e aneurysm might influence cardiovascular risk in patients with right-sided aortas. |
342) ld makes it necessary to reveal the toxic risk in populations of nontargeted organis |
343) This article explores risk in professional nursing practice. |
344) een reported to be associated with cancer risk in several types of cancer. |
345) em to be responsible for an increased CDV risk in these patients. |
346) nt women among the most vulnerable and at-risk group. |
347) ctories of suicidal ideation in this high-risk group and how these relate to posthos |
348) surgery for lung cancer represent a high-risk group because of electrolyte imbalanc |
349) e must target dialysis patients as a high-risk group. |
350) E severity, especially in identifying low-risk group. |
351) children of deprived obese parents are a risk group for the development of childhoo |
352) ve selective preventive programme for the risk group of children of depressed mother |
353) ls than boys reporting sexual experience (risk ratio 1.30, 95% CI 1.15, 1.47). |
354) ted with significantly improved survival (risk ratio [RR] 0.23, 95% confidence inter |
355) iated with moderate underweight (relative risk ratio [RRR] = 1.09; 95% confidence in |
356) It is critical to rapidly reassess the risk-benefit ratio of this drug for any pa |
357) The risk/benefit ratio must be carefully consi |
358) ional studies are warranted to verify the risk/benefit ratio of warfarin, which appe |
359) d education has been shown to reduce high-risk behavior among adolescents, but in In |
360) aracteristics, and higher drug and sexual risk behavior among male clients of FSWs. |
361) associated with increased odds of sexual risk behavior in both US-born (OR = 2.17, |
362) rt, and social discrimination) and sexual risk behavior. |
363) paminergic neurotransmission may modulate risk-taking behavior through an interactiv |
364) morrhage and when an appropriate exposure risk is available, especially a history of |
365) ation of nanomaterials which could pose a risk is desirable and developments are und |
366) present in a pig carcass may be low, the risk is not zero. |
367) ter clinical use for identifying women at risk is of limited value. |
368) We argue professional risk is socially constructed and understoo |
369) ols to assist in the identification of at-risk patients. |
|